Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Addition of a Low Fixed Number of CD3 + Cells to CD34-Enriched Allografts: Effects on Engraftment, Graft-versus-Host Disease, and Survival after Related and Unrelated Peripheral Stem Cell Transplantation
2003
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors
2002
5 Treatment and prognostic factors in acute myeloid leukaemia
1996
PR1 vaccination in myeloid malignancies
2008
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
1997
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors
1990
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
2008
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation
1998
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Treatment of relapse after allogeneic bone marrow transplantation
1996
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Cytogenetics in acute leukemia
2003
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Mesenchymal stem cells in health and disease
2008 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
1998
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.
1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
1998
A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
2002
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Chronic myelogenous leukemia: A review
1996
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
2004
Cancer genes and the pathways they control
2004 Standout
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
2005 StandoutNobel
Inherited Predisposition to Acute Myeloid Leukemia
2014
Conservation, Variability and the Modeling of Active Protein Kinases
2007 StandoutNobel
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience
2006
Unusual complications after bone marrow transplantation for dyskeratosis congenita
1998
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Autoimmune hemolytic anemia in Kawasaki disease: a case report
1990
Sciatic nerve compression following bone marrow harvest
2000
Graft-versus-host disease
2009 Standout
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Molecules and mechanisms of the graft-versus-leukaemia effect
2004
Graft-versus-myeloma effect in two cases
1996
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Human umbilical cord blood: A clinically useful source of transplantable hematopoietic stem/progenitor cells
1990
Chronic Myelogenous Leukemia
2002
Donor leukocyte infusions in acute lymphocytic leukemia
2000
Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases
2001
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
1995
Transplants across human leukocyte antigen barriers
2002
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
2004 Standout
Bone marrow transplantation for chronic myeloid leukaemia: the effects of differing criteria for defining chronic phase on probabilities of survival and relapse
1997
Hematopoietic Stem-Cell Transplantation
2006 Standout
Allogeneic transplantation of blood stem cells: Coming of age?
2001
Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable
2004
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
2004
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Bone Marrow Transplantation
1994
Non‐myeloablative allografting from human leucocyte antigen‐identical sibling donors for treatment of acute myeloid leukaemia in first complete remission
2003
Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype
1998
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells
2003
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Alloreactive killer cells: hindrance and help for haematopoietic transplants
2003
Imatinib Mesylate — A New Oral Targeted Therapy
2002
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
The National Marrow Donor Program
1993
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
2001
Chronic Myeloid Leukemia
1999
National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States
2005
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
2004
Infection in Organ-Transplant Recipients
1998 Standout
Transfusion-Associated Graft-versus-Host Disease
1990
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
2001
NK CELL RECOGNITION
2004 Standout
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
2001
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
1993
Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
2012
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
1995 Standout
Acute Myeloid Leukemia
2015 Standout
Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation
2002
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
2001
Stored placental blood for unrelated bone marrow reconstitution
1993
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation
1996
Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine
1999
Successful Treatment of Metastatic Renal Cell Carcinoma With a Nonmyeloablative Allogeneic Peripheral-Blood Progenitor-Cell Transplant: Evidence for a Graft-Versus-Tumor Effect
1999
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
2010
Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming Units
1997
Cancer treatment and survivorship statistics, 2016
2016 Standout
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
1994
How I treat refractory and early relapsed acute myeloid leukemia
2015
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia
2000
Human Adipose Tissue Is a Source of Multipotent Stem Cells
2002 Standout
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA
1992
The biology and treatment of acute lymphoblastic leukemia in adults
1995
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Antimicrobial strategies in the care of organ transplant recipients
1993
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
Haploinsufficiency of t e lomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita
2005 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Rapid Engraftment Without Significant Graft-Versus-Host Disease After Allogeneic Transplantation of CD34+ Selected Cells From Peripheral Blood
1997
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
1994
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
2002
Chronic myeloid leukemia: current treatment options
2001
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse
1994
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
2000
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of RC Ash being referenced
Clinical Course of Late-Onset Bone Marrow Transplant Nephropathy
1993
Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.
1988
Bone marrow transplantation for Fanconi anemia
1995
Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant
1987
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose
1993
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose
1993
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
1992
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia
1994
Bone marrow transplantation for Fanconi anemia
1995
Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
1992
Experiences of the first 493 unrelated marrow donors in the National Marrow Donor Program
1993
Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
1995
T-cell depletion of HLA-identical transplants in leukemia
1991
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]
1993
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
1992
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]
1993
Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.
1991
Third-party-mediated graft rejection and graft-versus-host disease after T-cell-depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism
1989
T-cell depletion of HLA-identical transplants in leukemia
1991